Investigating the synergic effects of valproic acid and crocin on BDNF and GDNF expression in epidermal neural crest stem cells

• Autorzy: Baharvand Z. , Nabiuni M. , Tahmaseb M. , Amini E. , Pandamooz S.
• Języki publikacji: EN

Abstrakty

EN

Following nerve tissue damage, various events, such as inflammatory responses, microglial activation, endoplasmic reticulum stress, and apoptosis, can occur, which all lead to cell death, prevent axonal growth, and cause axonal circumvolution. So far, several researchers have tended to adopt strategies to reduce the harmful conditions associated with neurological disorders, and stem‑cell‑based therapy is one of those promising strategies. Epidermal neural crest stem cells (EPI‑NCSCs) are a type of stem cell that has widely been employed for the treatment of various neurological disorders. It has been suggested that these stem cells perform their supportive actions primarily through the release of different neurotrophic factors. Hence, in this study, the neuroprotective impacts of valproic acid (VPA) and crocin were evaluated on the mRNA expression levels of brain‑derived neurotrophic factor (BDNF) and glial‑cell‑derived neurotrophic factor (GDNF) in EPI‑NCSCs. In this research, we isolated EPI‑NCSCs from the hair follicles of the rat whisker pad. Then, the cells were treated with different concentrations of VPA and crocin for 72 h. Subsequently, an MTT assay was performed to define the suitable concentrations of drugs. Finally, real‑time PCR was performed to evaluate the mRNA expression levels of BDNF and GDNF in these stem cells. The results of the MTT assay showed that the treatment of EPI‑NCSCs with 1 mM VPA and 1.5 mM crocin, and the co‑treatment with 1 mM VPA and 500 µM crocin, led to the survival and proliferation of these stem cells. Moreover, the real‑time PCR results revealed that both VPA and crocin, both individually and in combination, can significantly increase the expression levels of BDNF and GDNF in EPI‑NCSCs. According to the findings of this study, both VPA and crocin, alone and in combination, are potential candidates for enhancing the capacity of EPI‑NCSCs to differentiate into neural lineages. Therefore, the co‑treatment of EPI‑NCSCs with these drugs can be employed for the treatment of various neurological disorders, such as spinal cord injury.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2020
• Tom: 80
• Numer: 1
• Opis fizyczny: p.38-46,fig.,ref.

Twórcy

autor

Baharvand Z.

• Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

autor

Nabiuni M.

• Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

autor

Tahmaseb M.

• Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

autor

Amini E.

• Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

autor

Pandamooz S.

• Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Bibliografia

• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Therapeut 138: 155–175.
• Almutawaa W, Kang NH, Pan Y, Niles LP (2014) Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid. Basic Clin Pharmacol 115: 216–221.
• Bunge MB (2008) Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 31: 262–269.
• Buzgoova K, Graban J, Balagova L, Hlavacova N, Jezova D (2019) Brain derived neurotrophic factor expression and DNA methylation in response to subchronic valproic acid and/or aldosterone treatment. Croat Med J 60: 71.
• Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. Biomed Res Int 2010: 1–18.
• Chen AI, Xiong LJ, Tong Y U, Mao M (2013) The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed Rep 1: 167–176.
• Chen S, Ye J, Chen X, Shi J, Wu W, Lin W, Li S (2018) Valproic acid attenuates traumatic spinal cord injury‑induced inflammation via STAT1 and NF‑κB pathway dependent of HDAC3. J Neuroinflamm 15: 150.
• Chu T, Zhou H, Lu L, Kong X, Wang T, Pan B, Feng S (2015) Valproic acid‑mediated neuroprotection and neurogenesis after spinal cord injury: from mechanism to clinical potential. Regen Med 10: 193–209.
• Harvey AR, Lovett SJ, Majda BT, Yoon JH, Wheeler LP, Hodgetts SI (2015) Neurotrophic factors for spinal cord repair: which, where, how and when to apply, and for what period of time? Brain Res 1619: 36–71.
• Hu YF, Zhang ZJ, Sieber-Blum M (2006) An epidermal neural crest stem cell (EPI-NCSC) molecular signature. Stem Cells 24: 2692–2702.
• Jung GA, Yoon JY, Moon BS, Yang DH, Kim HY, Lee SH, Choi KY (2008) Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta‑catenin‑Ras‑ERK‑p21 Cip/WAF1 pathway. BMC Cell Biol 9: 66.
• Khazdair MR, Boskabady MH, Hosseini M, Rezaee R, Tsatsakis AM (2015) The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed 5: 376.
• Kim AJ, Shi Y, Austin RC, Werstuck GH (2005) Valproate protects cells from ER stress‑induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase‑3. J Cell Sci 118: 89–99.
• Li Z, Wu F, Zhang X, Chai Y, Chen D, Yang Y, Wang Z (2017) Valproate attenuates endoplasmic reticulum stress‑induced apoptosis in SH‑SY5Y cells via the AKT/GSK3β signaling pathway. Int J Mol Sci 18: 315.
• Lin G, Zhang H, Sun F, Lu Z, Reed‑Maldonado A, Lee YC, Lue TF (2016) Brain‑derived neurotrophic factor promotes nerve regeneration by activating the JAK/STAT pathway in Schwann cells. Transl Androl Urol 5: 167.
• Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real‑time quantitative PCR and the 2−ΔΔCT method. Methods 25: 402–408.
• Lv L, Han X, Sun Y, Wang X, Dong Q (2012) Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro. Exp Neurol 233: 783–790.
• Marsh S E, Blurton‑Jones M (2017) Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support. Neurochem Int 106: 94–100.
• Martínez‑Morales PL, Revilla A, Ocana I, Gonzalez C, Sainz P, McGuire D, Liste I (2013) Progress in stem cell therapy for major human neurological disorders. Stem Cell Rev Rep 9: 685–699.
• Nagahara A H, Tuszynski M H (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10: 209.
• Neirinckx V, Coste C, Rogister B, Wislet‑Gendebien S (2013) Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med 2: 284–296.
• Pandamooz S, Saied MS, Nabiuni M, Dargahi L, Pourghasem M (2016) Evaluation of epidermal neural crest stem cells in organotypic spinal cord slice culture platform. Folia Biol 62: 263.
• Pandamooz S, Naji M, Alinezhad F, Zarghami A, Pourghasem M (2013) The influence of cerebrospinal fluid on epidermal neural crest stem cells may pave the path for cell‑based therapy. Stem Cell Res Ther 4: 84.
• Pandamooz S, Salehi  MS, Safari A, Azarpira N, Heravi  M, Ahmadiani A, Dargahi L (2019) Enhancing the expression of neurotrophic factors in epidermal neural crest stem cells by valproic acid: A potential candidate for combinatorial treatment. Neurosci Lett 704: 8–14.
• Razavi BM, Sadeghi M, Abnous K, Hasani FV, Hosseinzadeh H (2017) Study of the role of CREB, BDNF, and VGF neuropeptide in long term antidepressant activity of crocin in the rat cerebellum. Iran J Pharm Res 16: 1452.
• Salehi  MS, Borhani‑Haghighi A, Pandamooz S, Safari A, Dargahi  L, Dianatpour  M, Tanideh N (2019) Dimethyl fumarate up‑regulates expression of major neurotrophic factors in the epidermal neural crest stem cells. Tissue Cell 56: 114–120.
• Samini F, Samarghandian S (2016) Neuroprotective effects of Crocus Sativus L. and its main constituents. Der Pharma Lett 8: 25–9.
• Scheuing L, Chiu C T, Liao H M, Linares G R, Chuang D M (2014) Preclinical and clinical investigations of mood stabilizers for Huntington’s disease: what have we learned? Int J Biol Sci 10: 1024.
• Sieber-Blum M, Grim M, Hu YF, Szeder V (2004) Pluripotent neural crest stem cells in the adult hair follicle. Dev Dynam 231: 258–269.
• Sieber‑Blum M (2010) Epidermal neural crest stem cells and their use in mouse models of spinal cord injury. Brain Res Bull 83: 189–193.
• Sieber-Blum M, Grim M (2004) The adult hair follicle: cradle for pluripotent neural crest stem cells. Birth Defects Res C 72: 162–172.
• Sieber‑Blum M, Hu Y (2008) Epidermal neural crest stem cells (EPI‑NCSC) and pluripotency. Stem Cell Rev 4: 256–260.
• Sieber‑Blum M, Schnell L, Grim M, Hu YF, Schneider R, Schwab ME (2006) Characterization of epidermal neural crest stem cell (EPI‑NCSC) grafts in the lesioned spinal cord. Mol Cell Neurosci 32: 67–81.
• Silva NA, Sousa N, Reis RL, Salgado AJ (2014) From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol 114: 25–57.
• Tang S, Machaalani R, Waters KA (2010) Immunolocalization of pro‑and mature‑brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus. Brain Res 1354: 1–14.
• Umka J, Mustafa S, El Beltagy M, Thorpe A, Latif L, Bennett G, Wigmore PM (2010) Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 166: 15–22.
• Vahdati Hassani F, Naseri V, Razavi BM, Mehri S, Abnous K, Hosseinzadeh H (2014) Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. DARU 22: 16.
• Walker M, Xu XM (2018) History of glial cell line‑derived neurotrophic factor (GDNF) and its use for spinal cord injury repair. Brain Sci 8: 109.
• Wang K, Zhang L, Rao W, Su N, Hui H, Wang L, Fei Z (2015) Neuroprotective effects of crocin against traumatic brain injury in mice: Involvement of notch signaling pathway. Neurosci Lett 591: 53–58.
• Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Chuang DM (2008) Histone deacetylase inhibitors up‑regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychoph 11: 1123–1134.
• Yorgun M A, Rashid K, Aslanidis A, Bresgen C, Dannhausen K, Langmann T (2017) Crocin, a plant‑derived carotenoid, modulates microglial reactivity. Biochem Biophys Rep 12: 245–250.
• Yoshii A, Constantine-Paton  M (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70: 304–322

Identyfikatory

DOI

10.21307/ane‑2020‑004